The city of Mesa, Arizona, currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Recruiting
This is a randomized, double-blinded, placebo-controlled multicenter study to evaluate the safety and efficacy of DWN12088 in patients with Idiopathic Pulmonary Fibrosis.
Gender:
All
Ages:
40 years and above
Trial Updated:
04/16/2024
Locations: Pulmonary Associates, PA, Mesa, Arizona
Conditions: Idiopathic Pulmonary Fibrosis